Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Are ERM (ezrin/radixin/moesin) proteins targets for autoantibodies in demyelinating neuropathies?
Reply to comment: Month of birth and risk of multiple sclerosis: confounding and adjustments.
The Blood-Brain Barrier in Multiple Sclerosis: MicroRNAs as Key Regulators.
MRI relaxation in the presence of fictitious fields correlates with myelin content in normal rat brain.
[Chronic inflammatory demyelinating polyradiculoneuropathy revealing essential thrombocythemia].
A Swiss real world best practice experience in three different clinical settings of the 6 hour fingolimod first dose observation procedure.
Mechanisms of cell-cell interaction in oligodendrogenesis and remyelination after stroke.
Diffusion tensor magnetic resonance imaging in very early onset pediatric multiple sclerosis.
Automated reference region extraction and population-based input function for brain [(11)C]TMSX PET image analyses.
Paraneoplastic Neuromyelitis Optica Spectrum Disorders: Three New Cases and A Review of the Literature.
Effect of comorbidity on mortality in multiple sclerosis.
Comorbidities at multiple sclerosis diagnosis.
Autoantigens and autoantibodies in multiple sclerosis.
Consequences of perinatal bisphenol A exposure in a mouse model of multiple sclerosis.
Treatment of Experimental Autoimmune Encephalomyelitis by Co-Delivery of Disease Associated Peptide and Dexamethasone in Acetalated Dextran Microparticles.
Deficiency in the mRNA export mediator Gle1 impairs Schwann cell development in the zebrafish embryo.
[Pelvic floor muscles training, electrical stimulation, bladder training and lifestyle interventions to manage lower urinary tract dysfunction in multiple sclerosis: A systematic review].
MRI measures of neurodegeneration in multiple sclerosis: implications for disability, disease monitoring, and treatment.
The node of Ranvier in CNS pathology.
Multiple sclerosis in Germany: data analysis of administrative prevalence and healthcare delivery in the statutory health system.
T1- vs. T2-based MRI measures of spinal cord volume in healthy subjects and patients with multiple sclerosis.
Disparate Effects of Mesenchymal Stem Cells in Experimental Autoimmune Encephalomyelitis and Cuprizone-Induced Demyelination.
Testing different ICA algorithms and connectivity analyses on MS patients.
Sleep disturbances in patients with multiple sclerosis.
Monitoring of active human herpes virus 6 infection in Iranian patients with different subtypes of multiple sclerosis.
Pages
« first
‹ previous
…
447
448
449
450
451
452
453
454
455
…
next ›
last »